4.6 Article

Enzalutamide Induces Apoptotic Insults to Human Drug-Resistant and -Sensitive Glioblastoma Cells via an Intrinsic Bax-Mitochondrion-Cytochrome C Caspase Cascade Activation Pathway

Related references

Note: Only part of the references are listed.
Review Oncology

Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches

Md Sahab Uddin et al.

Summary: Research has shown that glioma progression is closely linked to different types of epigenetic phenomena, such as chromatin modifications, DNA methylation, chromatin remodeling, and aberrant microRNA. Targeting the genes and proteins that control these alterations can be an effective way to treat GBM. Treatment approaches include histone deacetylase inhibitors and DNA methyltransferase inhibitors.

SEMINARS IN CANCER BIOLOGY (2022)

Article Oncology

UALCAN: An update to the integrated cancer data analysis platform

Darshan Shimoga Chandrashekar et al.

Summary: UALCAN is a web portal for exploring, analyzing, and visualizing cancer genomic, transcriptomic, and proteomic data, providing researchers with valuable insights into gene, protein, and pathway alterations in cancer, as well as evaluating patient survival data.

NEOPLASIA (2022)

Review Oncology

Dynamic Interactions between Tumor Cells and Brain Microvascular Endothelial Cells in Glioblastoma

Erika Testa et al.

Summary: This review discusses the dynamic interaction between tumor cells and brain microvascular endothelial cells (BMECs), providing evidence of how tumor cells utilize BMECs for the formation of new blood vessels. The interplay between tumor cells and BMECs involves multiple communication routes, including soluble factors, direct cell-cell contact, and extracellular vesicles. Furthermore, the review describes how this interaction modifies the structure, metabolism, and physiology of BMECs to promote tumor growth and invasiveness. Recent advances in high-throughput 3D models are briefly discussed for a better understanding of the complexity of BMECs-tumor cell interaction.

CANCERS (2022)

Article Medicine, General & Internal

Contribution of the Testosterone Androgen Receptor-PARD3B Signaling Axis to Tumorigenesis and Malignance of Glioblastoma Multiforme through Stimulating Cell Proliferation and Colony Formation

Jr-Di Yang et al.

Summary: The testosterone androgen receptor (AR)-PARD3B signaling axis plays an important role in the tumorigenesis and malignancy of human glioblastoma multiforme (GBM) by stimulating cell proliferation and colony formation. The study found that AR and PARD3B gene expressions were upregulated in GBM tissues, and there was a strong positive correlation between their expressions.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Biochemistry & Molecular Biology

Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance

Manendra Singh Tomar et al.

Summary: This review highlights various mechanisms behind TMZ resistance, including DNA repair, miRNA involvement, drug efflux, stem cells, etc., and proposes multiple strategies for successful treatment.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Oncology

Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance

Anmbreen Jamroze et al.

Summary: This article discusses how AR heterogeneity affects the response of prostate cancer to treatment, emphasizing the de novo resistance to ARSIs exhibited by AR-/lo PCa cells/clones. Several potential combinatorial strategies are proposed, such as combining ARSIs with stem cell targeting therapeutics, to co-target both AR+ and AR-/lo PCa cells and metastatic clones.

CANCER LETTERS (2021)

Article Agriculture, Multidisciplinary

Naringin Improves Osteoblast Mineralization and Bone Healing and Strength through Regulating Estrogen Receptor Alpha-Dependent Alkaline Phosphatase Gene Expression

Gong-Jhe Wu et al.

Summary: The study showed that naringin, a citrus flavonoid, can enhance bone mineralization and healing in osteoporosis-related bone diseases by activating ERα and ALP expression.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress

Christophe Olivier et al.

Summary: GBM is a common primary brain tumor with poor prognosis, driven by GSCs in specialized microenvironments and characterized by resistance to therapy. ROS play a dual role in controlling cellular stability, affecting cell cycle, progression, and drug resistance in GBM, while also inducing cell death programs like apoptosis and autophagy. The metabolic adaptation and stromal components in the microenvironment contribute to oxidative stress and drug resistance in GBM progression.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Review Biochemistry & Molecular Biology

Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials

Wei-Min Chung et al.

Summary: Ovarian cancer primarily originates from three cellular origins, with over 85% being epithelial ovarian carcinomas, and cancer stem/progenitor cells are considered cancer promoters. Activation of the androgen receptor is linked to the development and progression of ovarian cancer, with experimental studies showing positive effects of anti-androgen or anti-AR reagents in suppressing disease progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

Current Development of Glioblastoma Therapeutic Agents

Zilai Wang et al.

Summary: GBM is the most common and aggressive malignant primary brain tumor in humans, with limited success in treatment. Identifying and understanding key molecules and barriers for treatment resistance is crucial for discovering new potential therapeutic targets.

MOLECULAR CANCER THERAPEUTICS (2021)

Review Urology & Nephrology

Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer

Gaetan Devos et al.

Summary: The addition of potent androgen receptor signalling inhibitors in neoadjuvant hormonal therapy for high-risk prostate cancer is gaining interest, but the survival benefit remains inconclusive pending results from phase II trials. Patients with high-risk prostate cancer may require multimodal therapy for complete disease control, as conventional androgen deprivation therapy has not shown significant benefits in hard oncological end points. Studies using neoadjuvant ARSIs aim to gain insight into resistance mechanisms and personalized therapy.

NATURE REVIEWS UROLOGY (2021)

Article Cell Biology

Hypoxia Induced by Cobalt Chloride Triggers Autophagic Apoptosis of Human and Mouse Drug-Resistant Glioblastoma Cells through Targeting the PI3K-AKT-mTOR Signaling Pathway

Yuan-Wen Lee et al.

Summary: The study demonstrated that long-term treatment with CoCl2 induces hypoxia and subsequent autophagic apoptosis in drug-resistant glioblastoma cells by targeting the PI3K-AKT-mTOR pathway. Subsequent apoptotic insults lead to cell death.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Cell Biology

Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation

Jia Xia et al.

Summary: Caspase-8 plays a dual role in cell death and survival in cancer, and its upregulation in enzalutamide-resistant prostate cancer leads to increased NF-kappa B/IL-8 mediated survival signaling, contributing to therapy resistance. Targeting Caspase-8 and NF-kappa B may be a potential strategy to overcome enzalutamide resistance in CRPC.

CELL DEATH & DISEASE (2021)

Review Cell Biology

Sex-Specific Differences in Glioblastoma

Anna Carrano et al.

Summary: Sex differences exist in brain tumors, with males having higher incidence and worse outcomes in GBM compared to females. Estrogen plays a protective role in GBM, while upregulation of androgen receptors and testosterone may have detrimental effects. Hormones and the immune system play important roles in the GBM microenvironment.

CELLS (2021)

Article Oncology

Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma

Nan Zhao et al.

Summary: Targeting the androgen receptor has shown promise in treating glioblastoma, with AR antagonists like enzalutamide inhibiting the proliferation of GBM cells and decreasing the population of glioma cancer stem cells in both in vitro and in vivo studies. This suggests that AR antagonists could be repurposed for clinical applications in treating GBM by targeting CSCs.

FRONTIERS IN ONCOLOGY (2021)

Article Biotechnology & Applied Microbiology

Dihydrotestosterone Induces Proliferation, Migration, and Invasion of Human Glioblastoma Cell Lines

DulceCarolina Rodriguez-Lozano et al.

ONCOTARGETS AND THERAPY (2020)

Review Oncology

ARe we there yet? Understanding androgen receptor signaling in breast cancer

Anna R. Michmerhuizen et al.

NPJ BREAST CANCER (2020)

Article Endocrinology & Metabolism

Testosterone Promotes Glioblastoma Cell Proliferation, Migration, and Invasion Through Androgen Receptor Activation

Dulce Carolina Rodriguez-Lozano et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Review Medicine, General & Internal

Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells

Kouji Izumi et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Review Urology & Nephrology

Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications

Zachary J. Solomon et al.

SEXUAL MEDICINE REVIEWS (2019)

Editorial Material Oncology

AR Signaling in Human Malignancies: Prostate Cancer and Beyond

Emmanuel S. Antonarakis

CANCERS (2018)

Article Multidisciplinary Sciences

Mechanistic insights into caspase-9 activation by the structure of the apoptosome holoenzyme

Yini Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Cell Biology

Bax and Bak Pores: Are We Closing the Circle?

Katia Cosentino et al.

TRENDS IN CELL BIOLOGY (2017)

Review Biotechnology & Applied Microbiology

Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications

Silvia Anahi Valdes-Rives et al.

BIOMED RESEARCH INTERNATIONAL (2017)

Review Immunology

Cytochrome c as a Potentially Clinical Useful Marker of Mitochondria and Cellular Damage

Theodoros Eleftheriadis et al.

FRONTIERS IN IMMUNOLOGY (2016)

Review Medicine, Research & Experimental

Emerging treatment strategies for glioblastoma multiforme

Steven K. Carlsson et al.

EMBO MOLECULAR MEDICINE (2014)

Review Biochemistry & Molecular Biology

Regulation of CD95/Fas signaling at the DISC

I. N. Lavrik et al.

CELL DEATH AND DIFFERENTIATION (2012)

Article Endocrinology & Metabolism

GATA-3 Transduces Survival Signals in Osteoblasts Through Upregulation of bcl-xL Gene Expression

Ruei-Ming Chen et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2010)

Article Biochemistry & Molecular Biology

Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway

S. Inoue et al.

CELL DEATH AND DIFFERENTIATION (2009)

Review Biochemistry & Molecular Biology

The role of mitochondria in apoptosis

Seon-Yong Jeong et al.

BMB REPORTS (2008)

Review Clinical Neurology

Epidemiology and molecular pathology of glioma

Judith A. Schwartzbaum et al.

NATURE CLINICAL PRACTICE NEUROLOGY (2006)

Article Biochemistry & Molecular Biology

Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1

XJ Jiang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)